Vestibular rehabilitation ameliorates chronic dizziness through the SIRT1 axis

Frontiers in Aging Neuroscience

Volumn 6, Issue MAR, 2014, Pages

  Kao, Chung Lan ^a,b   Tsai, Kun Ling ^a,b   Cheng, Yuan Yang ^b,c   Kuo, Chia Hua ^d   Lee, Shin Da ^e   Chan, Rai Chi ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d UNIVERSITY OF TAIPEI   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Dizziness; Exercise; FoxO; Oxidative stress; SIRT1

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN P53; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SIRTUIN 1;

ADULT; AGED; ARTICLE; CATALYSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DIZZINESS; ENZYME ACTIVITY; EXERCISE; FEMALE; HUMAN; MALE; OXIDATIVE STRESS; PROTEIN EXPRESSION; UPREGULATION; VESTIBULAR FUNCTION;

EID: 84898053302     PISSN: None     EISSN: 16634365     Source Type: Journal    
DOI: 10.3389/fnagi.2014.00027     Document Type: Article

References (66)

1. Bisdorff, A., Von Brevern, M., Lempert, T., and Newman-Toker, D. E. (2009). Classification of vestibular symptoms: towards an international classification of vestibular disorders. J. Vestib. Res. 19, 1-13. doi: 10.3233/VES-2009-0343
2. Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., and Sinclair, D. A. (2002). Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1. J. Biol. Chem. 277, 45099-45107. doi: 10.1074/jbc. M205670200
3. Boyer, F. C., Percebois-Macadre, L., Regrain, E., Leveque, M., Taiar, R., Seidermann, L., et al. (2008). Vestibular rehabilitation therapy. Neurophysiol. Clin. 38, 479-487. doi: 10.1016/j.neucli.2008.09.011
4. Brunet, A., Sweeney, L. B., Sturgill, J. F., Chua, K. F., Greer, P. L., Lin, Y., et al. (2004). Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303, 2011-2015. doi: 10.1126/science.1094637
5. Calabrese, V., Cornelius, C., Maiolino, L., Luca, M., Chiaramonte, R., Toscano, M. A., et al. (2010). Oxidative stress, redox homeostasis and cellular stress response in Meniere's disease: role of vitagenes. Neurochem. Res. 35, 2208-2217. doi: 10.1007/s11064-010-0304-2
6. Chen, P. Y., Hsieh, W. L., Wei, S. H., and Kao, C. L. (2012). Interactive wiimote gaze stabilization exercise training system for patients with vestibular hypofunction. J. Neuroeng. Rehabil. 9, 77. doi: 10.1186/1743-0003-9-77
7. Colledge, N. R., Wilson, J. A., Macintyre, C. C., and MacLennan, W. J. (1994). The prevalence and characteristics of dizziness in an elderly community. Age Ageing 23, 117-120. doi: 10.1093/ageing/23.2.117
8. Csiszar, A., Labinskyy, N., Jimenez, R., Pinto, J. T., Ballabh, P., Losonczy, G., et al. (2009). Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: role of circulating factors and SIRT1. Mech. Ageing Dev. 130, 518-527. doi: 10.1016/j.mad.2009.06.004
9. De Angelis, K., Schaan, B. D., Maeda, C. Y., Dall'Ago, P., Wichi, R. B., and Irigoyen, M. C. (2002). Cardiovascular control in experimental diabetes. Braz. J. Med. Biol. Res.35, 1091-1100. doi: 10.1590/S0100-879X2002000900010
10. de Kreutzenberg, S. V., Ceolotto, G., Papparella, I., Bortoluzzi, A., Semplicini, A., Dalla Man, C., et al. (2010). Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes 59, 1006-1015. doi: 10.2337/db09-1187
11. Dieterich, M., and Eckhardt-Henn, A. (2004). Neurological and somatoform vertigo syndromes. Nervenarzt 75, 281-302. doi: 10.1007/s00115-003-1678-z
12. Dominguez, M. O. (2005). Treatment and rehabilitation in vestibular neuritis. Rev. Laryngol. Otol. Rhinol. 126, 283-286.
13. Duan, W. (2013). Sirtuins: from metabolic regulation to brain aging. Front. Aging Neurosci. 5:36. doi: 10.3389/fnagi.2013.00036
14. Lezi, E., Lu, J., Burns, J. M., and Swerdlow, R. H. (2013). Effect of exercise on mouse liver and brain bioenergetic infrastructures. Exp. Physiol. 98, 207-219. doi: 10.1113/expphysiol.2012.066688
15. Eaton, D. A., and Roland, P. S. (2003). Dizziness in the older adult, Part 2. Treatments for causes of the four most common symptoms. Geriatrics 58, 46, 49-52.
16. Eckhardt-Henn, A., Best, C., Bense, S., Breuer, P., Diener, G., Tschan, R., et al. (2008). Psychiatric comorbidity in different organic vertigo syndromes. J. Neurol. 255, 420-428. doi: 10.1007/s00415-008-0697-x
17. Falone, S., D'Alessandro, A., Mirabilio, A., Cacchio, M., Di Ilio, C., Di Loreto, S., et al. (2012). Late-onset running biphasically improves redox balance, energy- and methylglyoxal-related status, as well as SIRT1 expression in mouse hippocampus. PloS ONE 7:e48334. doi: 10.1371/journal.pone.0048334
18. Gao, Z., and Ye, J. (2008). Inhibition of transcriptional activity of c-JUN by SIRT1. Biochem. Biophys. Res. Commun. 376, 793-796. doi: 10.1016/j.bbrc.2008.09.079
19. Ghosh, S., Pulinilkunnil, T., Yuen, G., Kewalramani, G., An, D., Qi, D., et al. (2005). Cardiomyocyte apoptosis induced by short-term diabetes requires mitochondrial GSH depletion. Am. J. Physiol. Heart Circ. Physiol. 289, H768-H776. doi: 10.1152/ajpheart.00038.2005
20. Guarente, L. (2013). Introduction: sirtuins in aging and diseases. Methods Mol. Biol. 1077, 3-10. doi: 10.1007/978-1-62703-637-5_1
21. Hariharan, N., Maejima, Y., Nakae, J., Paik, J., Depinho, R. A., and Sadoshima, J. (2010). Deacetylation of FoxO by Sirt1 plays an essential role in mediating starvation-induced autophagy in cardiac myocytes. Circ. Res. 107, 1470-1482. doi: 10.1161/CIRCRESAHA.110.227371
22. Herdman, S. J. (2007). Vestibular Rehabilitation. Philadelphia: F. A. Davis Company.
23. Herdman, S. J., Schubert, M. C., and Tusa, R. J. (2001). Strategies for balance rehabilitation: fall risk and treatment. Ann. N. Y. Acad. Sci. 942, 394-412. doi: 10.1111/j.1749-6632.2001.tb03762.x
24. Hori, Y. S., Kuno, A., Hosoda, R., and Horio, Y. (2013). Regulation of FOXOs and p53 by SIRT1 modulators under oxidative stress. PloS ONE 8:e73875. doi: 10.1371/journal.pone.0073875
25. Hubbard, B. P., and Sinclair, D. A. (2014). Small molecule SIRT1 activators for the treatment of aging and age-related diseases. Trends Pharmacol. Sci. doi: 10.1016/j.tips.2013.12.004 [Epub ahead of print].
26. Jacobson, G. P., and Newman, C. W. (1990). The development of the Dizziness Handicap Inventory. Arch. Otolaryngol. Head Neck Surg. 116, 424-427. doi: 10.1001/archotol.1990.01870040046011
27. Kang, E. B., Kwon, I. S., Koo, J. H., Kim, E. J., Kim, C. H., Lee, J., et al. (2013). Treadmill exercise represses neuronal cell death and inflammation during Abeta-induced ER stress by regulating unfolded protein response in aged presenilin 2 mutant mice. Apoptosis 18,1332-1347. doi: 10.1007/s10495-013-0884-9
28. Kao, C. L., Chen, L. K., Chang, Y. L., Yung, M. C., Hsu, C. C., Chen, Y. C., et al. (2010a). Resveratrol protects human endothelium from H(2)O(2)-induced oxidative stress and senescence via SirT1 activation. J. Atheroscler. Thromb. 17, 970-979. doi: 10.5551/jat.4333
29. Kao, C. L., Chen, L. K., Chern, C. M., Hsu, L. C., Chen, C. C., and Hwang, S. J. (2010b). Rehabilitation outcome in home-based versus supervised exercise programs for chronically dizzy patients. Arch. Gerontol. Geriatr. 51, 264-267. doi: 10.1016/j.archger.2009.11.014
30. Kim, S. E., Ko, I. G., Shin, M. S., Kim, C. J., Jin, B. K., Hong, H. P. et al. (2013). Treadmill exercise and wheel exercise enhance expressions of neutrophic factors in the hippocampus of lipopolysaccharide-injected rats. Neurosci. Lett. 538, 54-59. doi: 10.1016/j.neulet.2013.01.039
31. Kobayashi, Y., Furukawa-Hibi, Y., Chen, C., Horio, Y., Isobe, K., Ikeda, K., et al. (2005). SIRT1 is critical regulator of FOXO-mediated transcription in response to oxidative stress. Int. J. Mol. Med. 16, 237-243.
32. Koltai, E., Szabo, Z., Atalay, M., Boldogh, I., Naito, H., Goto, S., et al. (2010). Exercise alters SIRT1, SIRT6, NAD and NAMPT levels in skeletal muscle of aged rats. Mech. Ageing Dev. 131, 21-28. doi: 10.1016/j.mad.2009.11.002
33. Kops, G. J., Dansen, T. B., Polderman, P. E., Saarloos, I., Wirtz, K. W., Coffer, P. J., et al. (2002). Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress. Nature 419, 316-321. doi: 10.1038/nature01036
34. Langley, E., Pearson, M., Faretta, M., Bauer, U. M., Frye, R. A., Minucci, S., et al. (2002). Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J. 21, 2383-2396. doi: 10.1093/emboj/21.10.2383
35. Lavu, S., Boss, O., Elliott, P. J., and Lambert, P. D. (2008). Sirtuins - novel therapeutic targets to treat age-associated diseases. Nat. Rev. Drug Discov. 7, 841-853. doi: 10.1038/nrd2665
36. Lezi, E., Lu, J., Burns, J. M., and Swerdlow, R. H. (2013). Effect of exercise on mouse liver and brain bioenergetic infrastructures. Exp. physiol. 98, 207-219. doi: 10.1113/expphysiol.2012.066688
37. Lin, L., Hron, J. D., and Peng, S. L. (2004). Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21, 203-213. doi: 10.1016/j.immuni.2004.06.016
38. Lin, T. J., Peng, C. H., Chiou, S. H., Liu, J. H., Lin Chung, W., Tsai, C. Y., et al. (2011). Severity of lens opacity, age, and correlation of the level of silent information regulator T1 expression in age-related cataract. J. Cataract Refract. Surg. 37, 1270-1274. doi: 10.1016/j.jcrs.2011.02.027
39. Ljubicic, V., Khogali, S., Renaud, J. M., and Jasmin, B. J. (2012). Chronic AMPK stimulation attenuates adaptive signaling in dystrophic skeletal muscle. Am. J. Physiol. Cell Physiol. 302, C110-C121. doi: 10.1152/ajpcell.00183.2011
40. Luo, J., Nikolaev, A. Y., Imai, S., Chen, D., Su, F., Shiloh, A., et al. (2001). Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107, 137-148. doi: 10.1016/S0092-8674(01)00524-4
41. Luxon, L. M. (2004). Evaluation and management of the dizzy patient. J. Neurol. Neurosurg. Psychiatry 75(Suppl 4), iv45-52. doi: 10.1136/jnnp.2004.055285
42. Milne, J. C., and Denu, J. M. (2008). The Sirtuin family: therapeutic targets to treat diseases of aging. Curr. Opin. Chem. Biol. 12, 11-17. doi: 10.1016/j.cbpa.2008.01.019
43. Min, S. W., Sohn, P. D., Cho, S. H., Swanson, R. A., and Gan, L. (2013). Sirtuins in neurodegenerative diseases: an update on potential mechanisms. Front. Aging Neurosci. 5:53. doi: 10.3389/fnagi.2013.00053
44. Moreau, M., Neveu, M., Stephan, S., Noblesse, E., Nizard, C., Sadick, N. S., et al. (2007). Enhancing cell longevity for cosmetic application: a complementary approach. J. Drugs Dermatol. 6, s14-s19.
45. Nemoto, S., and Finkel, T. (2002). Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295, 2450-2452. doi: 10.1126/science.1069004
46. Niehaus, W. G. Jr., and Samuelsson, B. (1968). Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur. J. Biochem. 6, 126-130. doi: 10.1111/j.1432-1033.1968.tb00428.x
47. Ou, X., Lee, M. R., Huang, X., Messina-Graham, S., and Broxmeyer, H. E. (2014). SIRT1 positively regulates autophagy and mitochondria function in embryonic stem cells under oxidative stress. Stem Cells doi: 10.1002/stem.1641 [Epub ahead of print].
48. Paparella, M. M., Alleva, M., and Bequer, N. G. (1990). Dizziness. Primary Care 17, 299-308.
49. Pardo, P. S., and Boriek, A. M. (2011). The physiological roles of Sirt1 in skeletal muscle. Aging 3, 430-437.
50. Porciuncula, F., Johnson, C. C., and Glickman, L. B. (2012). The effect of vestibular rehabilitation on adults with bilateral vestibular hypofunction: a systematic review. J. Vestib. Res. 22, 283-298. doi: 10.3233/VES-120464
51. Raponi, G., Alpini, D., Volonte, S., Capobianco, S., and Cesarani, A. (2003). The role of free radicals and plasmatic antioxidant in Meniere's syndrome. Int. Tinnitus J. 9, 104-108.
52. Salminen, A., and Kaarniranta, K. (2010). Insulin/IGF-1 paradox of aging: regulation via AKT/IKK/NF-kappaB signaling. Cell. Signal. 22, 573-577. doi: 10.1016/j.cellsig.2009.10.006
53. Sauve, A. A., Wolberger, C., Schramm, V. L., and Boeke, J. D. (2006). The biochemistry of sirtuins. Annu. Rev. Biochem. 75, 435-465. doi: 10.1146/annurev.biochem.74.082803.133500
54. Schubert, M. C., and Minor, L. B. (2004). Vestibulo-ocular physiology underlying vestibular hypofunction. Phys. Therapy 84, 373-385.
55. Schug, T. T., Xu, Q., Gao, H., Peres-da-Silva, A., Draper, D. W., Fessler, M. B., et al. (2010). Myeloid deletion of SIRT1 induces inflammatory signaling in response to environmental stress. Mol. Cell. Biol. 30, 4712-4721. doi: 10.1128/MCB.00657-10
56. Semaan, M. T., Alagramam, K. N., and Megerian, C. A. (2005). The basic science of Meniere's disease and endolymphatic hydrops. Curr. Opin. Otolaryngol. Head Neck Surg. 13, 301-307. doi: 10.1097/01.moo.0000186335.44206.1c
57. Shetty, P. K., Galeffi, F., and Turner, D. A. (2014). Nicotinamide pre-treatment ameliorates NAD(H) hyperoxidation and improves neuronal function after severe hypoxia. Neurobiol. Dis. 62, 469-478. doi: 10.1016/j.nbd.2013.10.025
58. Takumida, M., Anniko, M., and Ohtani, M. (2003). Radical scavengers for Meniere's disease after failure of conventional therapy: a pilot study. Acta Otolaryngol. 123, 697-703.
59. Telian, S. A., and Shepard, N. T. (1996). Update on vestibular rehabilitation therapy. Otolaryngol. Clin. North Am. 29, 359-371.
60. Tinetti, M. E. (1986). Performance-oriented assessment of mobility problems in elderly patients. J. Am. Geriatr. Soc. 34, 119-126.
61. Williams, C. B., and Gurd, B. J. (2012). Skeletal muscle SIRT1 and the genetics of metabolic health: therapeutic activation by pharmaceuticals and exercise. Appl. Clin. Genet. 5, 81-91. doi: 10.2147/TACG.S31276
62. Wu, P. F., Xie, N., Zhang, J. J., Guan, X. L., Zhou, J., Long, L. H., et al. (2013). Resveratrol preconditioning increases methionine sulfoxide reductases A expression and enhances resistance of human neuroblastoma cells to neurotoxins. J. Nutr. Biochem. 24, 1070-1077. doi: 10.1016/j.jnutbio.2012.08.005
63. Xiong, H., Dai, M., Ou, Y., Pang, J., Yang, H., Huang, Q., et al. (2013). SIRT1 expression in the cochlea and auditory cortex of a mouse model of age-related hearing loss. Exp. Gerontol. 51C, 8-14. doi: 10.1016/j.exger.2013.12.006.
64. Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., et al. (2004). Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 23, 2369-2380. doi: 10.1038/sj.emboj.7600244
65. Yoshizaki, T., Schenk, S., Imamura, T., Babendure, J. L., Sonoda, N., Bae, E. J., et al. (2010). SIRT1 inhibits inflammatory pathways in macrophages and modulates insulin sensitivity. Am. J. Physiol. Endocrinol. Metab. 298, E419-E428. doi: 10.1152/ajpendo.00417.2009
66. Zeng, H. T., Fu, Y. C., Yu, W., Lin, J. M., Zhou, L., Liu, L., et al. (2013). SIRT1 prevents atherosclerosis via liverXreceptor and NFkappaB signaling in a U937 cell model. Mol. Med. Rep. 8, 23-28. doi: 10.3892/mmr.2013.1460